tranexamic acid has been researched along with Kahler Disease in 3 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH | 1 |
| Kim, SW | 1 |
| Kim, WC | 1 |
| Chul-Hyun, L | 1 |
| Go, BS | 1 |
| de la Puente, P | 1 |
| Muz, B | 1 |
| Gilson, RC | 1 |
| Azab, F | 1 |
| Luderer, M | 1 |
| King, J | 1 |
| Achilefu, S | 1 |
| Vij, R | 1 |
| Azab, AK | 1 |
| Hoshino, Y | 1 |
| Hatake, K | 1 |
| Muroi, K | 1 |
| Tsunoda, S | 1 |
| Suzuki, T | 1 |
| Miwa, A | 1 |
| Sakamoto, S | 1 |
| Miura, Y | 1 |
3 other studies available for tranexamic acid and Kahler Disease
| Article | Year |
|---|---|
Hemorrhagic bullous colitis in a patient with multiple myeloma.
Topics: Aged; Amyloidosis; Antifibrinolytic Agents; Blister; Bone Density Conservation Agents; Colitis, Isch | 2013 |
3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.
Topics: Bone Marrow; Bone Marrow Cells; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytokines; Doxorubi | 2015 |
Bleeding tendency caused by the deposit of amyloid substance in the perivascular region.
Topics: Adrenochrome; Amyloid; Amyloidosis; Blood Vessels; Female; Hematoma; Hemostatics; Humans; Middle Age | 1993 |